| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.27 | 8e-14 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-13 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.29 | 6e-13 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.3 | 8e-13 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.27 | 1e-12 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.27 | 1e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-12 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-12 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-12 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.28 | 4e-12 |